Selling Capsule Skincare in China, Japan: Filing Paths for Import Brands

Asia anchors global skincare demand, with China plus Japan ranking among the three largest beauty markets in the world. For capsule brands, both countries reward preparation. Each runs its own filing system, each expects a local responsible party, and each treats efficacy claims differently from the EU or the US. Brands that map the route before tooling a capsule line avoid the expensive outcome of finished inventory that cannot clear customs.

There is good news for the format itself. Regulators in both markets classify products by formula plus claims, not by delivery form. A facial oil capsule, a sleeping mask capsule, and a body lotion capsule all follow the same pathway as any other skincare product with a similar formula. What decides the route is what the label promises.

Under the Cosmetics Supervision and Regulation, imported general cosmetics follow a filing route on the NMPA online platform. The dossier covers the product formula, a full ingredient list, quality standards, a label draft, test reports, plus a safety assessment. A Chinese responsible person must be appointed, and the filing takes effect once the materials pass formality review. Products claiming whitening, sun protection, anti-hair loss, or new effects enter the special cosmetics track instead, which requires pre-market registration supported by human efficacy testing. Industry practice puts registration at roughly six to twelve months, while a clean filing moves in weeks. Cross-border e-commerce offers a lighter entry for listed platforms, though purchase limits apply, so most brands treat it as a test channel rather than the main route.

Japan regulates cosmetics under the PMD Act. General cosmetics require notification before import, and the importing entity must hold a cosmetics manufacturing and sales license, so foreign brands appoint a local marketing authorization holder to file on their behalf. Labels follow Japanese conventions, supported by a published list of accepted efficacy claims that keeps wording conservative. Products marketed with medicated claims such as whitening or anti-aging move into the quasi-drug category, which needs pre-market approval with ingredient justification. Planning the claim set early is therefore the cheapest compliance decision a brand can make.

The paperwork overlaps heavily, so a brand preparing for one market is most of the way toward the other:

• Full formula with percentages, plus supplier details for every raw material
• Safety assessment, with product test reports from qualified laboratories where required
• Label artwork drafted for the destination language, from ingredient order to warnings
• Proof of manufacturing quality at the filling factory, such as an ISO 22716 certificate

Capsule formats carry quiet advantages inside a dossier. Anhydrous fills remove the need to justify a preservative system, which shortens one of the longer safety discussions. Sealed, light-shielding shells support shelf life arguments without heavy antioxidant loading, and the stability data reviewers expect is easier to generate when the fill never touches air. Fill weight is fixed by the encapsulation process itself, so per-dose quantities are simple to document, batch after batch. Even packaging review benefits, since blisters plus cartons are familiar secondary formats to both regulators.

Start with the claim set, not the formula, and the rest of the project falls into order. Share your target market, price positioning, and intended product line with our team. CapsulesBiotech replies with a formula direction, fill volumes from 0.2ml to 1ml, a shell choice between plant-based and food grade gelatin, plus a production schedule that fits your filing timeline in China, Japan, or beyond.